We expect Medtronic stock to trade sideways post-Q2 results announcement, with its revenues and earnings expected to miss the street estimates marginally.
We expect Medtronic stock to trade sideways post-Q2 results announcement, with its revenues and earnings expected to miss the street estimates marginally.